VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,281,000 | -0.5% | 512,051 | +10.8% | 0.93% | +47.3% |
| Q4 2015 | $4,302,000 | -25.7% | 462,051 | -10.0% | 0.63% | -14.7% |
| Q3 2015 | $5,791,000 | -11.1% | 513,390 | 0.0% | 0.74% | +15.8% |
| Q2 2015 | $6,515,000 | +28.9% | 513,390 | -5.5% | 0.64% | +21.3% |
| Q1 2015 | $5,054,000 | -4.2% | 543,390 | +47.5% | 0.53% | -41.5% |
| Q4 2014 | $5,275,000 | +132.7% | 368,390 | +68.7% | 0.90% | +221.1% |
| Q3 2014 | $2,267,000 | +0.1% | 218,390 | +56.0% | 0.28% | -49.8% |
| Q2 2014 | $2,265,000 | +114.5% | 140,000 | +115.4% | 0.56% | +131.5% |
| Q1 2014 | $1,056,000 | -10.4% | 65,000 | -31.6% | 0.24% | -26.5% |
| Q4 2013 | $1,179,000 | – | 95,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |